The circulating proteome and cancer risk: a systematic literature review and meta-analysis of 26 prospective studies with genetic validation.

Dillman A, An H, Huang Z, Chan WC, Blagden S, Parsaeian M, Atkins JR, Smith-Byrne K, Travis RC

Open source

DOI
10.1016/j.ebiom.2025.106117
Published
2026 Feb
Container
EBioMedicine
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ebiom.2025.106117,
  title = {The circulating proteome and cancer risk: a systematic literature review and meta-analysis of 26 prospective studies with genetic validation.},
  author = {Dillman A and An H and Huang Z and Chan WC and Blagden S and Parsaeian M and Atkins JR and Smith-Byrne K and Travis RC},
  year = {2026},
  journal = {EBioMedicine},
  doi = {10.1016/j.ebiom.2025.106117},
  url = {https://doi.org/10.1016/j.ebiom.2025.106117}
}

RIS

TY  - JOUR
TI  - The circulating proteome and cancer risk: a systematic literature review and meta-analysis of 26 prospective studies with genetic validation.
AU  - Dillman A
AU  - An H
AU  - Huang Z
AU  - Chan WC
AU  - Blagden S
AU  - Parsaeian M
AU  - Atkins JR
AU  - Smith-Byrne K
AU  - Travis RC
PY  - 2026
JO  - EBioMedicine
DO  - 10.1016/j.ebiom.2025.106117
UR  - https://doi.org/10.1016/j.ebiom.2025.106117
ER  - 

APA

A, D., H, A., Z, H., WC, C., S, B., M, P., JR, A., K, S., & RC, T. (2026). The circulating proteome and cancer risk: a systematic literature review and meta-analysis of 26 prospective studies with genetic validation.. EBioMedicine. https://doi.org/10.1016/j.ebiom.2025.106117

Source records